R.F. Sherwood
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Oncology
- Biotechnology top 5%
- Organic Chemistry
- Topics
- Peptidase Inhibition and Analysis (5 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)Cancer Research and Treatments (3 papers)
- Journals
- JNCI Journal of the National Cancer InstituteTrends in Biochemical SciencesBritish Journal of Cancer
- Partner nations
- United KingdomUnited StatesSouth Korea
In The Last Decade
R.F. Sherwood
12 papers receiving 488 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 341
- Radiology, Nuclear Medicine and Imaging 264
- Oncology 139
- Biotechnology 97
- Organic Chemistry 95
Countries citing papers authored by R.F. Sherwood
This map shows the geographic impact of R.F. Sherwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.F. Sherwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.F. Sherwood more than expected).
Fields of papers citing papers by R.F. Sherwood
This network shows the impact of papers produced by R.F. Sherwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.F. Sherwood. The network helps show where R.F. Sherwood may publish in the future.
Co-authorship network of co-authors of R.F. Sherwood
This figure shows the co-authorship network connecting the top 25 collaborators of R.F. Sherwood. A scholar is included among the top collaborators of R.F. Sherwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.F. Sherwood. R.F. Sherwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 81 | |
| 2 | 34 | |
| 3 | 18 | |
| 4 | 38 | |
| 5 | 2 | |
| 6 | 205 | |
| 7 | 10 | |
| 8 | 28 | |
| 9 | 50 | |
| 10 | 27 | |
| 11 | 1 | |
| 12 | 33 |
About R.F. Sherwood
R.F. Sherwood is a scholar working on Biotechnology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 527 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (264 citations), Biotechnology (97 citations) and Oncology (139 citations). R.F. Sherwood has collaborated with scholars based in United Kingdom, United States and South Korea. Frequent co-authors include RG Melton, K D Bagshawe, F Searle, Pari Antoniw, Springer Cj, SK Sharma, C. Wiblin, Roger G. Melton, G.T. Rogers and Tony Atkinson. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Trends in Biochemical Sciences and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.